THE EMERGENCE AND DEVELOPMENT OF PHARMACEUTICAL DEONTOLOGY: COUNTERFEIT MEDICINES: A GLOBAL PUBLIC HEALTH THREAT

Authors

Yadgarova Sitora Qahramonovna Lecturer in Pharmaceutical Deontology Department of General Subjects Asia International University, Bukhara, Uzbekistan

Keywords:

Counterfeit medicines, falsified drugs, pharmaceutical quality, public health, drug regulation, supply chain, patient safety, antimicrobial resistance, global health

Abstract

Counterfeit medicines represent a significant and growing challenge to global healthcare systems. These falsified pharmaceutical products may contain incorrect ingredients, improper dosages, or harmful substances, posing serious risks to patient safety. This article explores the scope of counterfeit medicines, their impact on public health, contributing factors, and strategies for prevention and control, supported by a review of relevant literature.

Downloads

Download data is not yet available.

References

Newton, P. N., et al. (2006). Counterfeit anti-infective drugs. The Lancet Infectious Diseases.

Nayyar, G. M. L., et al. (2012). Poor-quality antimalarial drugs in Africa and Southeast Asia. The Lancet Infectious Diseases.

World Health Organization (2017). A study on the public health and socioeconomic impact of substandard and falsified medical products.

Mackey, T. K., & Liang, B. A. (2011). The global counterfeit drug trade: patient safety and public health risks. Journal of Pharmaceutical Sciences.

The Lancet Global Health (various articles on antimicrobial resistance and counterfeit drugs).

Downloads

Published

2026-04-22

How to Cite

Yadgarova Sitora Qahramonovna. (2026). THE EMERGENCE AND DEVELOPMENT OF PHARMACEUTICAL DEONTOLOGY: COUNTERFEIT MEDICINES: A GLOBAL PUBLIC HEALTH THREAT. International Multidisciplinary Journal for Research & Development, 13(4), 1513–1514. Retrieved from https://ijmrd.in/index.php/imjrd/article/view/5867